Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

YU TZE NG

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology

NPI
1215041942
CMS profile
9413
Location
OVERLAND PARK, KS

General Payments · PY2018–2024

$110,736.11

  • Reported across 247 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$10,175.92

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $8,046.00 1
Food and Beverage $1,351.69 24
Travel and Lodging $778.23 3

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $9,306.75 12
LivaNova USA, Inc. $284.31 4
UCB, Inc. $199.92 5
BIOCODEX, INC. $124.96 1
CATALYST PHARMACEUTICALS, INC. $118.23 1
JAZZ PHARMACEUTICALS INC. $61.68 2
Neurelis, Inc. $59.26 2
NS Pharma, Inc. $20.81 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $18,821.24 57
PY2019 $70,123.62 114
PY2020 $8,623.32 22
PY2021 $2,030.69 9
PY2022 $460.71 8
PY2023 $500.61 9
PY2024 $10,175.92 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
BIOCODEX, INC. $124.96 06/22/2024 Food and Beverage Undisputed 01/23/2026 1146420462 CMS
CATALYST PHARMACEUTICALS, INC. $118.23 06/03/2024 Food and Beverage Undisputed 01/23/2026 1144453707 CMS
JAZZ PHARMACEUTICALS INC. $26.47 05/04/2024 Food and Beverage Undisputed 01/23/2026 1150204520 CMS
JAZZ PHARMACEUTICALS INC. $35.21 05/18/2024 Food and Beverage Undisputed 01/23/2026 1150204522 CMS
LivaNova USA, Inc. $13.99 06/26/2024 Food and Beverage Undisputed 01/23/2026 1152792509 CMS
LivaNova USA, Inc. $141.05 06/26/2024 Food and Beverage Undisputed 01/23/2026 1152792511 CMS
LivaNova USA, Inc. $10.26 07/09/2024 Food and Beverage Undisputed 01/23/2026 1152792507 CMS
LivaNova USA, Inc. $119.01 07/10/2024 Food and Beverage Undisputed 01/23/2026 1152792473 CMS
Neurelis, Inc. $30.31 05/16/2024 Food and Beverage Undisputed 01/23/2026 1145649358 CMS
Neurelis, Inc. $28.95 06/01/2024 Food and Beverage Undisputed 01/23/2026 1145649360 CMS
NS Pharma, Inc. $20.81 06/19/2024 Food and Beverage Undisputed 01/23/2026 1139459552 CMS
Takeda Pharmaceuticals U.S.A., Inc. $486.78 04/25/2024 Travel and Lodging Undisputed 01/23/2026 1137643104 CMS
Takeda Pharmaceuticals U.S.A., Inc. $124.99 05/17/2024 Food and Beverage Undisputed 01/23/2026 1137643106 CMS
Takeda Pharmaceuticals U.S.A., Inc. $49.99 05/17/2024 Food and Beverage Undisputed 01/23/2026 1137643108 CMS
Takeda Pharmaceuticals U.S.A., Inc. $49.99 05/17/2024 Food and Beverage Undisputed 01/23/2026 1137643110 CMS
Takeda Pharmaceuticals U.S.A., Inc. $101.90 05/18/2024 Travel and Lodging Undisputed 01/23/2026 1137643112 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.36 05/18/2024 Food and Beverage Undisputed 01/23/2026 1137643114 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.84 05/18/2024 Food and Beverage Undisputed 01/23/2026 1137643116 CMS
Takeda Pharmaceuticals U.S.A., Inc. $74.99 05/18/2024 Food and Beverage Undisputed 01/23/2026 1137643118 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.89 05/18/2024 Food and Beverage Undisputed 01/23/2026 1137643120 CMS
Takeda Pharmaceuticals U.S.A., Inc. $189.55 05/18/2024 Travel and Lodging Undisputed 01/23/2026 1137643122 CMS
Takeda Pharmaceuticals U.S.A., Inc. $8,046.00 05/26/2024 Consulting Fee Undisputed 01/23/2026 1137643124 CMS
Takeda Pharmaceuticals U.S.A., Inc. $115.47 06/10/2024 Food and Beverage Undisputed 01/23/2026 1137643126 CMS
UCB, Inc. $35.13 02/07/2024 Food and Beverage Undisputed 01/23/2026 1143330526 CMS
UCB, Inc. $2.14 04/10/2024 Food and Beverage Undisputed 01/23/2026 1143330530 CMS
UCB, Inc. $25.63 04/10/2024 Food and Beverage Undisputed 01/23/2026 1143330535 CMS
UCB, Inc. $34.93 04/30/2024 Food and Beverage Undisputed 01/23/2026 1143330539 CMS
UCB, Inc. $102.09 10/24/2024 Food and Beverage Undisputed 01/23/2026 1143330543 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.